Most GVHD patients should have insurance, which would be how they paid for an expensive bone marrow transplant.
Developing GVHD greatly increases the cost of post transplant care, and insurance companies should be willing to pay a lot for a cure which can greatly reduce these post transplant costs.
https://www.astctjournal.org/article/S2666-6367(23)01362-3/fulltext
- Forums
- ASX - By Stock
- MSB
- banter and General Discussion
banter and General Discussion, page-10077
-
-
- There are more pages in this discussion • 734 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.01 |
Change
0.010(1.01%) |
Mkt cap ! $1.147B |
Open | High | Low | Value | Volume |
99.0¢ | $1.01 | 98.5¢ | $685.3K | 686.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 29888 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 17750 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 64083 | 1.000 |
11 | 45654 | 0.995 |
12 | 140395 | 0.990 |
4 | 90369 | 0.985 |
6 | 46625 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.005 | 8300 | 7 |
1.010 | 28106 | 7 |
1.015 | 19487 | 7 |
1.020 | 69523 | 7 |
1.025 | 44990 | 6 |
Last trade - 11.05am 05/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |